We are live on ! Find out more
IHM

Iguana Healthcare Management Portfolio holdings

AUM $152M
1-Year Est. Return 48.74%
This Fund
S&P 500
This Quarter Est. Return
+31.61%
1 Year Est. Return
+48.74%
3 Year Est. Return
+142.13%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$561M
AUM Growth
+$315M
Cap. Flow
+$248M
Cap. Flow %
44.2%
Top 10 Hldgs %
35.2%
Holding
112
New
30
Increased
42
Reduced
5
Closed
33

Top Buys

Rank Stock Value
1
RARE icon
Ultragenyx Pharmaceutical
RARE
+$16.6M
2
ALXN
Alexion Pharmaceuticals
ALXN
+$12.9M
3
MDCO
Medicines Co
MDCO
+$12.8M
4
AMGN icon
Amgen
AMGN
+$12.7M
5
BIIB icon
Biogen
BIIB
+$12.6M

Top Sells

Rank Stock Value
1
BAX icon
Baxter International
BAX
+$6.11M
2
HCA icon
HCA Healthcare
HCA
+$3.85M
3
ILMN icon
Illumina
ILMN
+$3.51M
4
ELV icon
Elevance Health
ELV
+$2.58M
5
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
+$2.02M

Sector Composition

Rank Sector Weight
1 Healthcare 73.05%
2 Energy 0.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LITS
76
Lite Strategy Inc
LITS
$31.3M
$1.06M 0.19%
+30,000
New +$1.01M
SCYX icon
77
SCYNEXIS
SCYX
$48.7M
$968K 0.17%
3,125
+1,562
+100% +$330K
OMED
78
CALL
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
$572K 0.1%
+50,000
New +$582K
OMED
79
PUT
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
$572K 0.1%
+50,000
New +$582K
ABBV icon
80
CALL
AbbVie
ABBV
$439B
– –
-50,000
Closed -$3.1M
ALKS icon
81
Alkermes
ALKS
$8.43B
– –
-30,000
Closed -$1.3M
ALNY icon
82
CALL
Alnylam Pharmaceuticals
ALNY
$30B
– –
-25,000
Closed -$1.39M
BAX icon
83
Baxter International
BAX
$14B
– –
-135,000
Closed -$6.11M
CHRS icon
84
Coherus Oncology
CHRS
$185M
– –
-75,000
Closed -$1.27M
CLSD
85
DELISTED
Clearside Biomedical
CLSD
– –
-5,001
Closed -$526K
CYTK icon
86
Cytokinetics
CYTK
$10.6B
– –
-150,000
Closed -$1.42M
EXEL icon
87
CALL
Exelixis
EXEL
$12.5B
– –
-50,000
Closed -$391K
HCA icon
88
HCA Healthcare
HCA
$89.7B
– –
-50,000
Closed -$3.85M
ILMN icon
89
Illumina
ILMN
$28.8B
– –
-25,700
Closed -$3.51M
LAB icon
90
Standard BioTools
LAB
$307M
– –
-50,000
Closed -$452K
LLY icon
91
PUT
Eli Lilly
LLY
$1.09T
– –
-50,000
Closed -$3.91M
MCRB icon
92
Seres Therapeutics
MCRB
$47.6M
– –
-2,500
Closed -$1.45M
MCRB icon
93
PUT
Seres Therapeutics
MCRB
$47.6M
– –
-1,250
Closed -$726K
NVAX icon
94
PUT
Novavax
NVAX
$1.31B
– –
-2,500
Closed -$364K
RIGL icon
95
CALL
Rigel Pharmaceuticals
RIGL
$781M
– –
-5,000
Closed -$112K
RIGL icon
96
Rigel Pharmaceuticals
RIGL
$781M
– –
-15,000
Closed -$335K
SAGE
97
CALL
DELISTED
Sage Therapeutics
SAGE
– –
-50,000
Closed -$1.51M
SGMO
98
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
– –
-125,000
Closed -$724K
UNH icon
99
UnitedHealth
UNH
$365B
– –
-12,500
Closed -$1.76M
VTRS icon
100
Viatris
VTRS
$18.5B
– –
-25,000
Closed -$1.08M
1 2 3
4
5

Similar funds

HWP
Hefty Wealth Partners Auburn, Indiana $155M AUM 7.56% 1-Year Est. Return
PAM
PineView Asset Management Greenwich, Connecticut $166M AUM 27.74% 1-Year Est. Return
USG2
Union Square GP 2008 New York $172M AUM
LCM
Lee Capital Management New York $132M AUM 21% 1-Year Est. Return
FPF
FNY Partners Fund New York $185M AUM 32.59% 1-Year Est. Return
FIAS
FinTrust Investment Advisory Services Greenville, South Carolina $109M AUM
CII
Chapter IV Investors Charlotte, North Carolina $109M AUM 9.21% 1-Year Est. Return
OPWM
Oak Point Wealth Management Portage, Michigan $98M AUM

Iguana Healthcare Management's Q3 2016 Portfolio in Review

As of Q3 2016, Iguana Healthcare Management held 112 positions worth $561M, up 128% from $246M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Iguana Healthcare Management deployed $248M of net new capital in Q3 2016, opening 30 new positions and adding to 42 existing holdings. Its largest new stake was Bristol-Myers Squibb: 130,000 shares worth $7.01M.

By sector, the portfolio is most concentrated in Healthcare at 73% of assets, down from 78% a quarter earlier, followed by Energy.

On the sell side, the largest reduction was Elevance Health, an estimated $2.58M trimmed.

  • Iguana Healthcare Management's largest Q3 2016 buy was Bristol-Myers Squibb: 130,000 shares worth $7.01M.
  • Iguana Healthcare Management added most to Ultragenyx Pharmaceutical in Q3 2016, an estimated $16.6M increase.
  • Iguana Healthcare Management's biggest Q3 2016 reduction was Elevance Health, cutting an estimated $2.58M.
  • Iguana Healthcare Management fully exited Baxter International in Q3 2016, selling an estimated $6.11M.
  • Iguana Healthcare Management's ten largest holdings make up 35% of its $561M portfolio in Q3 2016.
  • Iguana Healthcare Management opened 30 new positions and closed 33 in Q3 2016.
  • Iguana Healthcare Management's portfolio value rose 128% quarter-over-quarter to $561M.

Based on Iguana Healthcare Management's 13F filing for Q3 2016, filed 14 Nov 2016.